Pathologic fracture and metastatic spinal cord compression in patients with prostate cancer and bone metastases

[1] Hernes E(2010)Initial management of prostate cancer: first year experience with the Norwegian National Prostate Cancer Registry BJU Int 105 805-811

[2] Kyrdalen A(2009)Chemotherapy in patients with castration-resistant prostate cancer Eur J Cancer 45 161-171

[3] Kvåle R(2007)Predictors of skeletal complications in men with hormone-refractory metastatic prostate cancer Urology 70 315-319

[4] Hem E(2005)Pre- and post-treatment daily life function in patients with hormone resistant prostate carcinoma treated with radiotherapy for spinal cord compression Radiother Oncol 74 259-265

[5] Klepp O(1994)Bone metastases: improving the therapeutic index Semin Oncol 21 630-656

[6] Acrona K(2006)Clinical features of metastatic bone disease and risk of skeletal morbidity Clin Cancer Res 12 6243s-6249s

[7] Fosså SD(1993)Vertebral fracture assessment using a semi-quantitative technique J Bone Miner Res 8 1137-1148

[8] Meulenbeld HJ(1997)Assessment of vertebral fractures in osteoporosis research J Rheumatol 24 1212-1214

[9] Hamberg P(2003)Prognostic model for predicting survival in men with hormone-refractory metastatic prostate cancer J Clin Oncol 21 1232-1237

[10] de Wit R(2009)Prevalence of skeletal complications and their impact on survival of hormone refractory prostate cancer patients in Japan Urology 73 1104-1109

[1] Hernes E(2010)Initial management of prostate cancer: first year experience with the Norwegian National Prostate Cancer Registry BJU Int 105 805-811

[2] Kyrdalen A(2009)Chemotherapy in patients with castration-resistant prostate cancer Eur J Cancer 45 161-171

[3] Kvåle R(2007)Predictors of skeletal complications in men with hormone-refractory metastatic prostate cancer Urology 70 315-319

[4] Hem E(2005)Pre- and post-treatment daily life function in patients with hormone resistant prostate carcinoma treated with radiotherapy for spinal cord compression Radiother Oncol 74 259-265

[5] Klepp O(1994)Bone metastases: improving the therapeutic index Semin Oncol 21 630-656

[6] Acrona K(2006)Clinical features of metastatic bone disease and risk of skeletal morbidity Clin Cancer Res 12 6243s-6249s

[7] Fosså SD(1993)Vertebral fracture assessment using a semi-quantitative technique J Bone Miner Res 8 1137-1148

[8] Meulenbeld HJ(1997)Assessment of vertebral fractures in osteoporosis research J Rheumatol 24 1212-1214

[9] Hamberg P(2003)Prognostic model for predicting survival in men with hormone-refractory metastatic prostate cancer J Clin Oncol 21 1232-1237

[10] de Wit R(2009)Prevalence of skeletal complications and their impact on survival of hormone refractory prostate cancer patients in Japan Urology 73 1104-1109